Table of Contents
- Scope and Themes
- What you need to know
- Definition
- Survey and forecast methodology
- Abbreviations and terms
- Abbreviations
- Terms
- Executive Summary
- FDM OTC analgesics market stagnant
- Aging nation to increase volume of sales by 1.35% annually through 2012
- External analgesics encroaching on sales
- Analgesic tablets dominate market but liquids growing fastest
- Leading brand Tylenol wins for most convincing marketing
- OTC marketing focused on older consumers and young mothers
- Drug stores are the primary destination for purchase
- Negative perception limits usage, especially among under-45s
- Store brands becoming more sophisticated
- Online advertising on the rise
- Minorities more likely to avoid store brands
- Under-55s more interested in newer product formats
- Potential for ' alert and pain-free' combination products
- From products to solutions
- Market Drivers
- An aging population
- Figure 1: U.S. population, by age, 2002-12
- Figure 2: Incidence of pain-inducing ailments, by age, January-October
2006
- New products for an aging population
- Figure 3: Bayer Aleve arthritis relief tablets, 2007
- Figure 4: CVS arthritis pain relief caplets, 2007
- Anti-inflammation marketing lagging
- Sugar-free chewables for diabetics
- Figure 5: Bayer sugar free chewable aspirin, 2007
- Shifting from prescription to OTC
- Figure 6: OTC analgesic usage and types of pain, 2002-06
- Fear of medication
- Fear of medications grows on medical research and advisories
- New ibuprofen sleep aid
- External analgesics
- Figure 7: FDM sales of external analgesics, at current and constant
prices, 2002-07
- Figure 8: Origin BioMedicinals Neuragen RL Nerve Pain Relief, 2007
- Figure 9: NaturalCare Joint Health Capsules, 2007
- Figure 10: Arkopharma Relief for Migraines, 2007
- Market Size and Trends
- Market size
- Figure 11: Total U.S. retail sales of OTC internal analgesics, at
current and constant prices, 2002-07
- Trends
- Increasing share of private label
- Figure 12: FDM sales of private label OTC analgesics, at current and
constant prices, 2002-07
- Figure 13: Trader Joe' s Trader Darwin' s Ibuprofen, 2007
- Targeting specific indications
- Figure 14: Excedrin Back & Body extra strength pain reliever, 2007
- Figure 15: Extra Strength Doan' s Pain Reliever, 2007
- Figure 16: Excedrin migraine pain relief, 2007
- Figure 17: Equate headache relief, 2007
- Preventing stomach irritation
- Figure 18: CVS Pharmacy enteric aspirin, 2007
- Figure 19: GlaxoSmithKline Ecotrin, 2007
- Market Segmentation
- Figure 20: FDM sales of OTC internal analgesics, segmented by type, 2005
and 2007
- Figure 21: Graph: FDM sales of OTC internal analgesics, by type, 2007
- Figure 22: Graph: Indexed FDM sales of OTC internal analgesics, by type,
2002-07
- Analgesic tablets
- Figure 23: FDM sales of OTC analgesic tablets, at current and constant
prices, 2002-07
- Analgesic liquids
- Figure 24: FDM sales of OTC analgesic liquids, at current and constant
prices, 2002-07
- Feminine pain relievers
- Figure 25: FDM sales of OTC feminine pain relievers, at current and
constant prices, 2002-07
- Supply Structure
- Introduction
- Companies and brands
- Figure 26: FDM sales of OTC internal analgesics in the U.S., 2004 and
2006
- Figure 27: Available physical forms of major OTC analgesic brands, 2007
- Figure 28: Available physical forms of major OTC analgesic brands, 2007
- Analgesic tablets
- Figure 29: FDM brand sales of analgesic tablets in the U.S., 2004 and
2006
- Analgesic liquids
- Figure 30: FDM brand sales of analgesic liquids in the U.S., 2004 and
2006
- Feminine pain relievers
- Figure 31: FDM brand sales of feminine pain relievers in the U.S., 2004
and 2006
- Advertising and Promotion
- Introduction
- McNeil Consumer Products
- Figure 32: Media expenditures for Tylenol, 2005 and 2006
- Tylenol
- Figure 33: Tylenol Arthritis Pain
- Figure 34: Tylenol Go Tabs (October 2006)
- Figure 35: Tylenol Promise (May 2007)
- Motrin
- Figure 36: Motrin IB and Children' s Motrin
- Wyeth Consumer Healthcare
- Figure 37: Media expenditures for Advil, 2005 and 2006
- Advil
- Figure 38: Advil PM (May 2007)
- Figure 39: Advil All Purpose (August 2007)
- Bayer Consumer Health
- Figure 40: Media expenditures for Bayer and Aleve, 2005 and 2006
- Aleve
- Figure 41: Aleve Over-50 Dancer (July 2007)
- Figure 42: Aleve Liquid Gels (August 2007)
- Bayer Aspirin
- Figure 43: Bayer Cardiac Care Unit (July 2007)
- Novartis Consumer Health
- Figure 44: Media expenditures for Excedrin, 2005 and 2006
- Excedrin
- Figure 45: Excedrin Headache Storm (September 2006)
- Figure 46: Excedrin Roller Coaster (July 2007)
- Figure 47: Excedrin Double Play (July 2007)
- Retail Distribution
- Introduction
- Figure 48: U.S. retail sales* of OTC internal analgesics, by channel,
2005 and 2007
- Figure 49: Average price per unit of OTC analgesics at FDM, by type, 2006
- Drug stores
- Figure 50: U.S. drug store sales of OTC internal analgesics, at current
and constant prices, 2002-07
- Supermarkets
- Figure 51: U.S. supermarket sales of OTC internal analgesics, at current
and constant prices, 2002-07
- Mass merchandisers
- Figure 52: U.S. mass merchandiser sales* of OTC internal analgesics, at
current and constant prices, 2002-07
- The Consumer: Product Usage
- Summary
- Usage
- Indications
- Usage of headache/pain relievers
- Figure 53: Usage of headache/pain relievers, by gender, January-October
2006
- Figure 54: Usage of headache/pain relievers, by age, January-October 2006
- Figure 55: Usage of headache/pain relievers, by household income,
January-October 2006
- Prevalence of types of pain
- Figure 56: Prevalence of types of pain, October 2007
- Figure 57: Prevalence of types of pain, by gender, October 2007
- OTC usage for specific pain types
- Figure 58: OTC analgesic usage for specific types of pain,
January-October 2006
- Figure 59: OTC analgesic usage for specific types of pain, 2002-06
- Pain from menstruation
- Figure 60: Pain from menstruation, by age, October 2007
- Indications for OTC pain relief
- Figure 61: Indications for OTC pain relief, January-October 2006
- Figure 62: Indications for OTC pain relief, by gender, January-October
2006
- Figure 63: Indications for OTC pain relief, by age, January-October 2006
- Figure 64: Sole indications for OTC pain relief, January-October 2006
- Children and OTC pain medication
- Figure 65: Children and OTC pain medications, by gender, October 2007
- Figure 66: Children and OTC pain medications, by age, October 2007
- Forms of OTC analgesics
- Figure 67: Forms of OTC analgesics, by age, January-October 2006
- Race/ethnicity
- Figure 68: Usage of headache/pain relievers, by race/ethnicity,
January-October 2006
- Figure 69: Indications for OTC pain relief, by race/ethnicity,
January-October 2006
- The Consumer: OTC Brands
- Summary
- Brand observations
- Store brands
- Popularity of OTC brands
- Figure 70: Popularity of OTC analgesic brands, January-October 2006
- Figure 71: Popularity of OTC analgesic brands, by age, January-October
2006
- Figure 72: Popularity of OTC analgesic brands, by household income,
January-October 2006
- Figure 73: Popularity of OTC analgesic brands, by race/ethnicity,
January-October 2006
- Brands and specific actions
- Figure 74: Brands and specific actions, October 2007
- Frequency of use by brand
- Figure 75: Frequency of use, by brand, October 2007
- Attitudes Towards OTC Products
- Summary
- Consumer attitudes
- Sources of information
- Attitudes toward OTC pain medication
- Figure 76: Attitudes toward OTC pain medication, October 2007
- Figure 77: Attitudes toward OTC pain medication, by gender, October 2007
- Figure 78: Attitudes toward OTC pain medication, by race/ethnicity,
October 2007
- Reasons to limit usage
- Figure 79: Reasons to limit usage, October 2007
- Figure 80: Reasons to limit usage, by age, October 2007
- Attitudes toward enhanced drug action
- Figure 81: Attitudes toward enhanced drug action, October 2007
- Figure 82: Attitudes toward enhanced drug action, by gender, October 2007
- Figure 83: Attitudes toward enhanced drug action, by age, October 2007
- Sources of information
- Figure 84: Sources of information, by gender, October 2007
- Figure 85: Sources of information, by age, October 2007
- Figure 86: Sources of information, by presence of children in household,
October 2007
- Future and Forecast
- Future trends
- Homeopathic remedies on the rise
- Figure 87: Hyland' s BackAche with Arnica Homeopathic tablets, 2007
- Advertising shifts from consumer to patient, and from push to online
- Solutions, not products
- Vast arena for expansion in combination products as yet untapped
- Catering to the aging Boomer
- Easy to swallow
- New pharmaceutical stops menstruation
- Market forecast
- OTC analgesics market
- Figure 88: Forecast of total U.S. retail sales of OTC internal
analgesics, at current and constant prices, 2007-12
- Private label OTC analgesics
- Figure 89: Forecast of U.S. FDM sales of private label OTC analgesics,
at current and constant prices, 2007-12
- Analgesic tablets
- Figure 90: Forecast of U.S. FDM sales of OTC analgesic tablets, at
current and constant prices, 2007-12
- Analgesic liquids
- Figure 91: Forecast of U.S. FDM sales of OTC analgesic liquids, at
current and constant prices, 2007-12
- Feminine pain relievers
- Figure 92: Forecast of U.S. FDM sales of OTC feminine pain relievers, at
current and constant prices, 2007-12
- Forecast factors
- Appendix: Trade Associations
|
Related Report
|
View Cart
